Contact PI/Project LeaderOFOTOKUN, IGHOVWERHA Other PIs
Awardee OrganizationEMORY UNIVERSITY
Description
Abstract Text
ABSTRACT
The overarching goal of the Emory Stimulating Access to Research in Residency R38 (Emory R38) program is
to leverage the rich infrastructure and the interdisciplinary research environment at Emory University to provide
> 12 months of clinical and translational research training for resident physicians in the field of infectious
diseases, allergy, microbiology, and immunology. The long-term goal is to expand the pool of physician
scientists engaged in these areas of research. We will foster an Emory R38 specific mentoring program
tailored to the training needs of resident physicians; and build a systematic approach for identifying and
recruiting a diverse cohort of resident physicians into the program. The Emory R38 program will attract trainees
from our Internal Medicine Residency Categorical Track with interest in pursuing a career as a physician
scientist focused on clinical and translational research. As a result of the size and diversity of the Emory
residency training program, we have a highly competitive pool of eligible candidates whose research interests,
skills and career development will be significantly enhanced by a program that provides individualized didactic
and mentored research training by an outstanding multidisciplinary team of preceptors and will provide
sufficient (80% protected) time to gain skills and expertise in clinical and translational research. Research
training will be personalized, and the duration of training will be 12 months or more depending on the resident’s
training needs and future career plans, while fulfilling all requirements for clinical board certification. The
research training plan, which has been approved by the American Board of Internal Medicine (ABIM), will be
spread across the last 2 years of the Internal Medicine Residency in protected blocks of >3 months; after the
3rd year, trainees will also serve 12 months in the Research Chief Resident position to focus on mentored
research training to complete their research projects prior to beginning fellowship training. Research training
addressed by the selected seminars, workshops, and short coursework for the Emory R38 program will include
the fundamentals and ethics of clinical and translational research, practical research skill acquisition, effective
communication, time management, understanding research funds flow in an academic health center, building a
successful research team, job negotiation, identifying grant opportunities, and navigating an IRB and/or animal
protocol, as appropriate for the research project. Preceptors with mentoring experience and NIH-funded
research projects in broad areas of the target fields have been strategically assembled for this program,
including applied immunology and microbiology, disease management, diagnostics, health equity,
therapeutics, and vaccinology. Preceptors are offered mentorship training that includes topics such as practical
research skill-building needed for research supervision and effective mentoring of physician-scientists, aligning
goals and expectations, and mentoring for a diverse and inclusive biomedical research workforce.
Public Health Relevance Statement
Project Narrative
The overarching goal of the Emory R38 program is to leverage the rich infrastructure and the interdisciplinary
research environment at Emory to provide clinical and translational research training for resident physicians in
the field of infectious diseases, allergy, microbiology, and immunology. The long-term goal is to expand the
pool of physician scientists engaged in these areas of research. This goal will be operationalized through the
development and sustained support of a structured research training program that offers an in-depth training in
the fundamentals of clinical and translational research; fostering an Emory R38 specific mentoring program
that is tailored to the training needs of resident physicians; and building a systematic approach for identifying
and recruiting a diverse cohort of resident physicians into the program.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAmericanAnimalsAreaBiomedical ResearchBoard CertificationCOVID-19 pandemicClinicalClinical EthicsClinical ResearchClinical TrialsClinical and Translational Science AwardsCommunicable DiseasesCommunicationCreativenessDecision MakingDevelopmentDiagnosticDisease ManagementEducational CurriculumEducational workshopEligibility DeterminationEnvironmentEvaluationFellowshipFosteringFundingFunding OpportunitiesFutureGoalsGrantHealthHypersensitivityImmunologyInfrastructureInstitutionInstitutional Review BoardsInterdisciplinary StudyInternal MedicineLeadershipMediationMedical EducationMedicineMentored Clinical Scientist Development ProgramMentorsMentorshipMethodologyMicrobiologyNational Institute of Allergy and Infectious DiseaseNational Research Service AwardsOccupationsOutcomePhysician's RolePhysiciansPlayPositioning AttributeProcessProgram DevelopmentProtocols documentationResearchResearch MethodologyResearch PersonnelResearch Project GrantsResearch TrainingResidenciesResourcesRoleRotationScheduleScientistSenior ScientistSpecialty BoardsStructureSupervisionTNFSF15 geneTherapeuticTimeTime ManagementTrainingTraining ProgramsTraining and InfrastructureTranslational ResearchTranslationsUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesVaccinescareercareer developmentclinical careclinical trainingcohorteducation researchexpectationexperienceflexibilityfundamental researchhealth care qualityhealth equityimprovedinnovationinterestmultidisciplinarynext generationpandemic responseprogramsrecruitresponsesenior facultyskill acquisitionskillssuccessvaccinology
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
066469933
UEI
S352L5PJLMP8
Project Start Date
12-June-2023
Project End Date
31-May-2028
Budget Start Date
01-June-2024
Budget End Date
31-May-2025
Project Funding Information for 2024
Total Funding
$455,761
Direct Costs
$422,001
Indirect Costs
$33,760
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$455,761
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R38AI174306-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R38AI174306-02
Patents
No Patents information available for 5R38AI174306-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R38AI174306-02
Clinical Studies
No Clinical Studies information available for 5R38AI174306-02
News and More
Related News Releases
No news release information available for 5R38AI174306-02
History
No Historical information available for 5R38AI174306-02
Similar Projects
No Similar Projects information available for 5R38AI174306-02